CoChat

The Use of Vaccinia Hyperimmune Gammaglobulin in the Prophylaxis of Smallpox

Open access
Kempe, C. H., Bowles, C., Meiklejohn, G., Berge, T. O., Saint-Vincent, L., Babu, B. V. Sundara, Govindarajan, S., Ratnakannan, N. R., Downie, A. W., Murthy, V. R. · 2015 · Association Internationale des Soci�t�s de Microbiologie
Cited by 113

The DOI matches its Crossref record.

Abstract

This paper records an attempt to assess the prophylactic value of immune gammaglobulin, prepared from the serum of recently vaccinated adults, in the protection of close contacts of smallpox in Madras.The results serve to confirm findings of a previous study made in Madras in 1953, and show that the incidence of smallpox in close contacts given immune gamma-globulin prophylactically was about a quarter of that in the control contacts who received no such passive immunization-a statistically significant difference.Because of the limited supply of immune gamma-globulin, it is likely that its prophylactic use will be restricted to those especially at risk, for example, close unvaccinated family contacts, newborn infants and pregnant women.In a previous field trial of hyperimmune gamma- globulin for the prevention of smallpox'1 the number of cases involved was insufficient to give conclusive evidence of prophylactic value, although the results were highly suggestive.For this reason, the experiment was repeated in a co-operative venture involving the Department of Pediatrics of the University of Colorado School of Medicine, the Department of Bacteriology of the University of Liverpool; the World Health Organization, the Indian Council for Medical Research; the Madras State Government and the Corporation of Madras.STUDY METHODS * This is one of a series of studies carried out in March- April 1960 in Madras, India, with the purpose of shedding new light on a number of still unsolved problems in the epidemiology, immunology, pathogenesis, prevention and treatment of smallpox.The studies were conducted under the sponsorship of the World Health Organization; the Indian Council for Medical Research; the Director of General Health Services, Government of India; the Director of Medical Services, Government of Madras; the Commissioner, Corporation of Madras; the Health Officer, Corporation of Madras; the King Institute, Guindy; and the Infectious Diseases Hospital, Madras.They were supported by grants from the World Health Organization; the Virus and Rickettsial Disease Study Section, National Institutes of Health, Bethesda, Md., USA (Grant E-1632); and the Marcus Tullius Reynolds III Fund.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000389848

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 113

Metadata

Authors
Kempe, C. H., Bowles, C., Meiklejohn, G., Berge, T. O., Saint-Vincent, L., Babu, B. V. S., Govindarajan, S., Ratnakannan, N. R., Downie, A. W., & Murthy, V. R.
Venue
Association Internationale des Soci�t�s de Microbiologie
Publisher
S. Karger AG
Published
2015-04-15
Volume
25
Pages
228-229
OpenAlex
W2121048336
Cited by
113
References
0
FWCI
10.74
Type
book chapter
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Use of Vaccinia Hyperimmune Gammaglobulin in the Prophylaxis of Smallpox. https://app.cochat.ai/papers/10.1159/000389848
The paper
Kempe, C. H., Bowles, C., Meiklejohn, G., Berge, T. O., Saint-Vincent, L., Babu, B. V. S., Govindarajan, S., Ratnakannan, N. R., Downie, A. W., & Murthy, V. R. (2015). The Use of Vaccinia Hyperimmune Gammaglobulin in the Prophylaxis of Smallpox. Association Internationale des Soci�t�s de Microbiologie. https://doi.org/10.1159/000389848

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.